Virginia Retirement Systems’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $479K | Buy |
27,665
+3,000
| +12% | +$51.9K | ﹤0.01% | 759 |
|
|
2025
Q1 | $539K | Buy |
+24,665
| New | +$539K | ﹤0.01% | 729 |
|
|
2023
Q3 | $373K | Buy |
9,800
+3,000
| +44% | +$114K | ﹤0.01% | 771 |
|
|
2023
Q2 | $619K | Sell |
6,800
-4,000
| -37% | -$364K | 0.01% | 670 |
|
|
2023
Q1 | $712K | Sell |
10,800
-4,200
| -28% | -$277K | 0.01% | 639 |
|
|
2022
Q4 | $776K | Sell |
15,000
-1,000
| -6% | -$51.7K | 0.01% | 687 |
|
|
2022
Q3 | $1.09M | Buy |
+16,000
| New | +$1.09M | 0.01% | 548 |
|
|
2022
Q1 | $305K | Buy |
6,000
+400
| +7% | +$20.3K | ﹤0.01% | 970 |
|
|
2021
Q4 | $265 | Buy |
+5,600
| New | +$265 | ﹤0.01% | 1007 |
|